SECTION

#Stock Offering

Total 2 related articles

Live wire →

NewsTag

Featured

Taysha Gene Therapies Plunges on $200M Stock Offering at $6 Per Share

Lead report

美股

Lead report

Taysha Gene Therapies Plunges on $200M Stock Offering at $6 Per Share

Taysha Gene Therapies announced a $200 million public offering at $6 per share, causing a sharp after-hours selloff. The article analyzes the dilutive financing, pipeline progress, and investor concerns.

YayaNews2026-06-25 14:433 min

来源: Seeking Alpha

美股

IDEAYA Biosciences Prices $300M Public Offering at $27/Share, Precision Oncology Funding Moves

IDEAYA Biosciences announces a $300 million public offering priced at $27 per share, including common stock and pre-funded warrants. Proceeds will advance precision oncology drug development. Details on the offering, market reaction, and investment implications.

YayaNews2026-06-09 13:083 min来源: Seeking Alpha

Featured

Taysha Gene Therapies Plunges on $200M Stock Offering at $6 Per Share

IDEAYA Biosciences Prices $300M Public Offering at $27/Share, Precision Oncology Funding Moves

More Related Articles